Currently, I am the President & COO of OM1, where I lead company-wide operations, strategy, and execution across our data, technology, and AI-driven solutions. My focus is on scaling innovative real-world evidence (RWE) capabilities that deliver measurable value to life sciences and healthcare stakeholders.

Previously, I served as Chief Data Officer and SVP, RWD Solutions & Customer Success at ConcertAI, where I led the strategy, vision, and roadmap for oncology-focused real-world data products and ensured successful delivery of value across our data, technology, and services portfolio.

Prior to that, I was SVP of Analytics & Scientific Engagement at Panalgo, where I led scientific operations and drove adoption of Instant Health Data (IHD), a leading enterprise-scale real-world data analytics platform. Under my leadership, IHD expanded its use across pharmaceutical companies, medical device manufacturers, health plans, government agencies, and contract research organizations, supporting use cases ranging from feasibility assessments to comparative effectiveness research.

Earlier in my career, I led user and scientific engagement at Aetion, supporting the adoption of the Aetion Evidence Platform. I also served as a staff scientist at the Hutchinson Institute for Cancer Outcomes Research (HICOR) at Fred Hutchinson Cancer Center, where my research focused on improving the quality of cancer care while reducing its economic burden.

I am also a passionate educator and have designed and taught master’s- and doctoral-level courses at Columbia University and the City University of New York.

For fun I maintain Dot Data, a blog focused on visualizing the health of populations.

To read more about me check out my CV.